Cargando…
miRNAs and Multiple Myeloma: Focus on the Pathogenesis, Prognosis, and Drug Resistance
Multiple myeloma (MM) produces clonal plasma cells and aberrant monoclonal antibody accumulation in patients’ bone marrow (BM). Around 1% of all cancers and 13% of hematological malignancies are caused by MM, making it one of the most common types of cancer. Diagnostic and therapeutic methods for ma...
Autores principales: | Tavakoli Pirzaman, Ali, Ebrahimi, Pouyan, Hasanpour, Amir Hossein, Shakeri, Mahdi, Babajani, Bahareh, Pourali Ganji, Zahra, Babaei, Hedye, Rahmati, Amirhossein, Hosseinzadeh, Rezvan, Doostmohamadian, Shahrbanoo, Kazemi, Sohrab |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10515583/ https://www.ncbi.nlm.nih.gov/pubmed/37728167 http://dx.doi.org/10.1177/15330338231202391 |
Ejemplares similares
-
The Role of microRNAs in Regulating Cancer Cell Response to Oxaliplatin-Containing Regimens
por: Tavakoli Pirzaman, Ali, et al.
Publicado: (2023) -
Anticoagulant therapy in COVID‐19: A narrative review
por: Mohseni Afshar, Zeinab, et al.
Publicado: (2023) -
SARS-CoV-2 Omicron (B.1.1.529) Variant: A Challenge with COVID-19
por: Mohseni Afshar, Zeinab, et al.
Publicado: (2023) -
The Investigation into Neurotoxicity Mechanisms of Nonylphenol: A Narrative Review
por: Lotfi, Mandana, et al.
Publicado: (2021) -
The effect of propolis on 5-fluorouracil-induced cardiac toxicity in rats
por: Barary, Mohammad, et al.
Publicado: (2022)